FDA Inspection 1088026 — Neopharm Labs Inc.
The FDA completed an inspection of Neopharm Labs Inc. on March 19, 2019 in Blainville. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 19, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Blainville (Canada)